Coherus BioSciences: Q4 Earnings Snapshot

Published: 2025-03-10 16:33:17 ET CHRS

REDWOOD CITY, Calif. (AP) — REDWOOD CITY, Calif. (AP) — Coherus BioSciences Inc. (CHRS) on Monday reported a loss of $50.7 million in its fourth quarter.

On a per-share basis, the Redwood City, California-based company said it had a loss of 44 cents. Losses, adjusted for non-recurring costs and stock option expense, came to 28 cents per share.

The drug developer posted revenue of $54.1 million in the period.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CHRS at https://www.zacks.com/ap/CHRS

For copyright information, check with the distributor of this item, STATS Perform dba Automated Insights. , source Associated Press News